EP-547
- Generic Name
- EP-547
Study to Evaluate EP547 in Subjects With Cholestatic Pruritus Due to Primary Biliary Cholangitis or Primary Sclerosing Cholangitis
- First Posted Date
- 2022-09-01
- Last Posted Date
- 2024-10-14
- Lead Sponsor
- Escient Pharmaceuticals, Inc
- Target Recruit Count
- 62
- Registration Number
- NCT05525520
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States
🇺🇸UPMC Center for Liver Disease, Pittsburgh, Pennsylvania, United States
Evaluate the Safety, Tolerability, and PK of EP547 in Healthy Subjects and Subjects With Cholestatic or Uremic Pruritus
- First Posted Date
- 2020-08-12
- Last Posted Date
- 2023-06-12
- Lead Sponsor
- Escient Pharmaceuticals, Inc
- Target Recruit Count
- 89
- Registration Number
- NCT04510090
- Locations
- 🇦🇺
CMAX Clinical Research, Adelaide, South Australia, Australia
🇦🇺Monash Medical Centre, Clayton, Victoria, Australia
🇦🇺The Alfred Hospital, Melbourne, Victoria, Australia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath